Focus

Semax / Selank Mix.

Available Variants

20 mg

View lab reports Quality process

Research area: Focus

🛡️

For research purposes only. Not intended for use in humans or animals.

Neuroscience research

About Semax / Selank Mix

Semax / Selank Mix is studied in the context of neuroscience and cognitive research. Two distinct neuroscience-related signaling pathways are combined: BDNF-mediated effects via Semax and GABA-/enkephalin-mediated effects via Selank.

Research Application

Discussed in combination research as a way to simultaneously address cognitive (Semax, BDNF-mediated) and anxiolytic (Selank, GABA-/enkephalin-mediated) pathways. No dedicated combination study exists — the evidence comes from the separate research on each compound.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 20 mg

Form Lyophilized powder

Category Focus

Purity & Identity see lab reports →

Sequence / Structure Combination: Semax (7 aa, ACTH fragment) + Selank (7 aa, tuftsin analog)

Regulatory Status The combination itself has not been separately studied clinically; both individual compounds are approved drugs in Russia but not FDA approved in the US.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

Panikratova YR, et al. Doklady Biological Sciences. 2020;490:9–11. PMID 32342318
Dolotov OV, et al. Brain Res. 2006;1117(1):54–60. PMID 16996037
Zozulya AA, et al. Zh Nevrol Psikhiatr. 2008. PMID 18454096

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about Semax / Selank Mix?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview